1. "Breast Medicine Service"
  2. "Mark Robson"
  3. "Larry Norton"
Formats
  1. Meeting Abstract (44)
  2. Journal Article (39)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (83)
  2. Breast Medicine Service (83)
  3. Department of Medicine (83)
  4. Population Sciences Research Program (83)
  5. Solid Tumor Oncology Division (83)
  6. Survivorship Research (83)

More Groups

People
  1. Larry Norton (83)
  2. Mark Robson (83)
  3. Clifford Hudis (33)
  4. Kenneth Offit (29)
  5. Chau Dang (27)
  6. Edi Brogi (23)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (9)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Breast Cancer Research and Treatment (9)
  3. Laboratory Investigation (7)
  4. Cancer Research (6)
  5. American Journal of Human Genetics (5)
  6. Clinical Cancer Research (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (14)
  3. Nature Publishing Group (12)
  4. Springer (10)
  5. Cell Press (6)
  6. Nature Research (6)

More Publishers

Results (83)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of reactive changes on multigene testing: Histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores
    Journal Article

    Grabenstetter, A.; Brogi, E.; Thompson, D. M.; Blinder, V. S.; Norton, L.; Morrow, M.; Robson, M. E.; Wen, H. Y.
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • Pan-cancer assessment of the impact of intronic variants on cancer development and progression
    Meeting Abstract

    Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction
    Meeting Abstract

    Shen, S.; Solomon, V.; Williams, D.; Robson, M. E.; Norton, L.; Traina, T. A.; Iyengar, N. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Older patients with early-stage triple-negative breast cancer: The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Zhi, I.; Lake, D. E.; Ehrich, F.; Chen, Y.; Korc-Grodzicki, B.; Norton, L.; Robson, M. E.; Singh, J. C.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer
    Meeting Abstract

    Abuhadra, N.; Chen, Y.; Plitas, G.; Razavi, P.; Pareja, F.; Reis-Filho, J. S.; Wen, H. Y.; Khan, A. J.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The histologic and genomic features of breast cancers harboring genetic alterations in RecQ DNA helicases
    Meeting Abstract

    Kaur, G.; Selenica, P.; Gazzo, A.; Cartagena, L. C.; Daaboul, F.; Dopeso, H.; da Silva, E. M.; Ross, D.; Zhang, H.; Wen, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer
    Meeting Abstract

    Safonov, A. M.; Bandlamudi, C.; Selenica, P.; Marra, A.; Ferraro, E.; Mandelker, D.; Solit, D. B.; Berger, M. F.; Norton, L.; Powell, S. N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Change in HER2 status after neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in patients with HER2-positive early-stage breast cancer
    Meeting Abstract

    Ferraro, E.; Razavi, P.; Chandarlapaty, S.; Modi, S.; Wen, H. Y.; Brogi, E.; Norton, L.; Robson, M. E.; Dang, C. T.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save